Why the study?
Do different noninvasive devices (Omron HEM-9000AI vs. SphygmoCor CPV) yield comparable estimates of central systolic blood pressure in nontreated patients?
Do different noninvasive devices (Omron HEM-9000AI vs. SphygmoCor CPV) yield comparable estimates of central systolic blood pressure in nontreated patients?
There are notable differences in central systolic blood pressure estimations between the Omron HEM-9000AI and SphygmoCor CPV devices, highlighting the need for standardization before clinical use.
No takes yet. Share an insight, caveat, or question.
Device discrepancies in cSBP estimates warrant clinical caution; leaves open standardization and validation needs.
Fernandez et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: